Ravi Kolla, Ph.D.
Director, Technology Development
Ravi received his Ph.D. in Immunology from the University of California, San Diego (UCSD). As part of his doctoral research, he studied B cell activation and signal transduction and developed methods to use the innate immune system to bolster the antibody response against infectious agents. He continued his postdoctoral studies at the UCSD Medical School in the Division of Rheumatology, where he conducted research studying antibodies and B cells with anti-inflammatory properties in rheumatoid arthritis and systemic lupus erythematosus.
Prior to joining Technology Development in 2015, Ravi served as a Senior Project Manager within the Division of Vaccine Discovery at the La Jolla Institute where he oversaw numerous, highly-matrix programs that focused on utilizing the T cell immune response to protect against infectious viruses, bacteria, and allergens. Prior to this role, Ravi was employed at the Novartis Institute for Biomedical Research as a Project Manager in Drug Discovery managing numerous cross-functional and geographically diverse small molecule and biologic drug development programs across immunology, oncology, infectious disease, and muscular-skeletal disease. Throughout his career, he has gained significant expertise in human immunology and disease.
In Technology Development, he provides scientific expertise to support development of new business initiatives and faculty research projects.